Importer of Controlled Substances Application: Lipomed, 17623-17627 [2023-05916]
Download as PDF
17623
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–05911 Filed 3–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1159]
Importer of Controlled Substances
Application: Lipomed
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Lipomed has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 24, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 24, 2023.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
ADDRESSES:
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 9, 2023
Lipomed, 150 Cambridepark Drive,
Suite 705, Cambridge, Massachusetts
02140–2300, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) ...................................................................................................................................
Cathinone ..............................................................................................................................................................................
Methcathinone .......................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) ...................................................................................................................................
Pentedrone (a-methylaminovalerophenone) .........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ..........................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .....................................................................................................................................
Naphyrone .............................................................................................................................................................................
N-Ethylamphetamine .............................................................................................................................................................
N,N-Dimethylamphetamine ....................................................................................................................................................
Fenethylline ...........................................................................................................................................................................
Aminorex ................................................................................................................................................................................
4-Methylaminorex (cis isomer) ..............................................................................................................................................
Gamma Hydroxybutyric Acid .................................................................................................................................................
Methaqualone ........................................................................................................................................................................
Mecloqualone ........................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ........................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ......................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................
5-Fluoro-UR–144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) ...................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...........................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ............................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............................
FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate)
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ...............................................
THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .......................................................................
5F–AB–PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ............................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .....................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ..............
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ....................................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .......................................
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) .................................................................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ..............
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) ....................................................................................
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ..................................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ........................................................................................................
1-(5-Fluoropentyl)-1H-indazole-3-carboxamide .....................................................................................................................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .....................
4–CN–CUMYL–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78
(1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboximide).
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) .........................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ....................................................................................
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7042
7044
7047
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7104
7118
I
I
17624
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...........................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ......................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) .............................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .............................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ...............................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .......................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ..................................................................................
4-methyl-alpha-ethylaminopentiophenone (4–MEAP) ...........................................................................................................
N-ethylhexedrone ..................................................................................................................................................................
Alpha-ethyltryptamine ............................................................................................................................................................
Ibogaine .................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................
Lysergic acid diethylamide ....................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ....................................................................................................
Marihuana extract ..................................................................................................................................................................
Marihuana ..............................................................................................................................................................................
Tetrahydrocannabinols ..........................................................................................................................................................
Parahexyl ...............................................................................................................................................................................
Mescaline ...............................................................................................................................................................................
2C–T–2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) ................................................................................................
3,4,5-Trimethoxyamphetamine ..............................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................................
2,5-Dimethoxyamphetamine ..................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ............................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ......................................................................................................................................
3,4-Methylenedioxyamphetamine ..........................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ........................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ........................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ..................................................................................................................................
4-Methoxyamphetamine ........................................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ......................................................................................................................................
Alpha-methyltryptamine .........................................................................................................................................................
Bufotenine ..............................................................................................................................................................................
Diethyltryptamine ...................................................................................................................................................................
Dimethyltryptamine ................................................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Psilocyn .................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................................
4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ..................................................................................................
N-Ethyl-1-phenylcyclohexylamine ..........................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ..........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .....................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ....................................................................................................................................
N-Ethyl-3-piperidyl benzilate ..................................................................................................................................................
N-Methyl-3-piperidyl benzilate ...............................................................................................................................................
N-Benzylpiperazine ................................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ...........................................................................................................
2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ........................................................................................................
2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ...........................................................................................................
2C–H (2-(2,5-Dimethoxyphenyl) ethanamine) .......................................................................................................................
2C–I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ..............................................................................................................
2C–C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................
2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ..........................................................................................................
2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ...................................................................................................
2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ..........................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .............................................................................................................................
25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..........................................................
25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..........................................................
25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...............................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................
Butylone .................................................................................................................................................................................
Pentylone ...............................................................................................................................................................................
N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ..........................................................
a-PHP, alpha-Pyrrolidinohexanophenone .............................................................................................................................
a-PVP (alpha-pyrrolidinopentiophenone) ..............................................................................................................................
a-PBP (alpha-pyrrolidinobutiophenone) ................................................................................................................................
PV8, alpha-Pyrrolidinoheptaphenone ....................................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .........................................................................................................
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7548
7694
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
17625
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
Norfentanyl ............................................................................................................................................................................
Acetyldihydrocodeine .............................................................................................................................................................
Benzylmorphine .....................................................................................................................................................................
Codeine-N-oxide ....................................................................................................................................................................
Cyprenorphine .......................................................................................................................................................................
Desomorphine .......................................................................................................................................................................
Etorphine (except HCl) ..........................................................................................................................................................
Codeine methylbromide .........................................................................................................................................................
Dihydromorphine ...................................................................................................................................................................
Difenoxin ................................................................................................................................................................................
Heroin ....................................................................................................................................................................................
Hydromorphinol .....................................................................................................................................................................
Methyldesorphine ..................................................................................................................................................................
Methyldihydromorphine .........................................................................................................................................................
Morphine methylbromide .......................................................................................................................................................
Morphine methylsulfonate .....................................................................................................................................................
Morphine-N-oxide ..................................................................................................................................................................
Myrophine ..............................................................................................................................................................................
Nicocodeine ...........................................................................................................................................................................
Nicomorphine .........................................................................................................................................................................
Normorphine ..........................................................................................................................................................................
Pholcodine .............................................................................................................................................................................
Thebacon ...............................................................................................................................................................................
Acetorphine ............................................................................................................................................................................
Drotebanol .............................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ....................................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ........................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ........................................................................................................
Acetylmethadol ......................................................................................................................................................................
Allylprodine ............................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ............................................................................................................
Alphameprodine .....................................................................................................................................................................
Alphamethadol .......................................................................................................................................................................
Benzethidine ..........................................................................................................................................................................
Betacetylmethadol .................................................................................................................................................................
Betameprodine ......................................................................................................................................................................
Betamethadol .........................................................................................................................................................................
Betaprodine ...........................................................................................................................................................................
Clonitazene ............................................................................................................................................................................
Dextromoramide ....................................................................................................................................................................
Diampromide .........................................................................................................................................................................
Diethylthiambutene ................................................................................................................................................................
Dimenoxadol ..........................................................................................................................................................................
Dimepheptanol .......................................................................................................................................................................
Dimethylthiambutene .............................................................................................................................................................
Dioxaphetyl butyrate ..............................................................................................................................................................
Dipipanone .............................................................................................................................................................................
Ethylmethylthiambutene ........................................................................................................................................................
Etonitazene ............................................................................................................................................................................
Etoxeridine .............................................................................................................................................................................
Furethidine .............................................................................................................................................................................
Hydroxypethidine ...................................................................................................................................................................
Ketobemidone ........................................................................................................................................................................
Levomoramide .......................................................................................................................................................................
Levophenacylmorphan ..........................................................................................................................................................
Morpheridine ..........................................................................................................................................................................
Noracymethadol .....................................................................................................................................................................
Norlevorphanol ......................................................................................................................................................................
Normethadone .......................................................................................................................................................................
Norpipanone ..........................................................................................................................................................................
Phenadoxone .........................................................................................................................................................................
Phenampromide ....................................................................................................................................................................
Phenoperidine ........................................................................................................................................................................
Piritramide ..............................................................................................................................................................................
Proheptazine ..........................................................................................................................................................................
Properidine ............................................................................................................................................................................
Racemoramide ......................................................................................................................................................................
Trimeperidine .........................................................................................................................................................................
Phenomorphan ......................................................................................................................................................................
Propiram ................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ....................................................................................................................
Tilidine ...................................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .......................................................................................
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
8366
9051
9052
9053
9054
9055
9056
9070
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
17626
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
Para-Fluorofentanyl ...............................................................................................................................................................
3-Methylfentanyl ....................................................................................................................................................................
Alpha-Methylfentanyl .............................................................................................................................................................
Acetyl-alpha-methylfentanyl ...................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide .............................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .....................................................................................
Butyryl Fentanyl .....................................................................................................................................................................
Para-fluorobutyryl fentanyl .....................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ...............................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ...............................................................................................
Para-chloroisobutyryl fentanyl ...............................................................................................................................................
Isobutyryl fentanyl ..................................................................................................................................................................
Beta-hydroxyfentanyl .............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ..............................................................................................................................................
Alpha-methylthiofentanyl .......................................................................................................................................................
3-Methylthiofentanyl ...............................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ...................................................................
Thiofentanyl ...........................................................................................................................................................................
Beta-hydroxythiofentanyl .......................................................................................................................................................
Para-methoxybutyryl fentanyl ................................................................................................................................................
Ocfentanil ...............................................................................................................................................................................
Valeryl fentanyl ......................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) ...............................................................................
Cyclopropyl Fentanyl .............................................................................................................................................................
Cyclopentyl fentanyl ..............................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ...........................................................................................
Amphetamine .........................................................................................................................................................................
Methamphetamine .................................................................................................................................................................
Lisdexamfetamine ..................................................................................................................................................................
Phenmetrazine .......................................................................................................................................................................
Methylphenidate ....................................................................................................................................................................
Amobarbital ............................................................................................................................................................................
Pentobarbital ..........................................................................................................................................................................
Secobarbital ...........................................................................................................................................................................
Glutethimide ...........................................................................................................................................................................
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration
(FDA).
Nabilone .................................................................................................................................................................................
1-Phenylcyclohexylamine ......................................................................................................................................................
Phencyclidine .........................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) ...........................................................................................................................
Phenylacetone .......................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ......................................................................................................................................
Alphaprodine ..........................................................................................................................................................................
Anileridine ..............................................................................................................................................................................
Cocaine ..................................................................................................................................................................................
Codeine .................................................................................................................................................................................
Etorphine HCl ........................................................................................................................................................................
Dihydrocodeine ......................................................................................................................................................................
Oxycodone .............................................................................................................................................................................
Hydromorphone .....................................................................................................................................................................
Diphenoxylate ........................................................................................................................................................................
Ecgonine ................................................................................................................................................................................
Ethylmorphine ........................................................................................................................................................................
Hydrocodone .........................................................................................................................................................................
Levomethorphan ....................................................................................................................................................................
Levorphanol ...........................................................................................................................................................................
Isomethadone ........................................................................................................................................................................
Meperidine .............................................................................................................................................................................
Meperidine-intermediate-A ....................................................................................................................................................
Meperidine intermediate-B ....................................................................................................................................................
Meperidine intermediate-C ....................................................................................................................................................
Metazocine ............................................................................................................................................................................
Methadone .............................................................................................................................................................................
Methadone intermediate ........................................................................................................................................................
Metopon .................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ....................................................................................................................
Morphine ................................................................................................................................................................................
Oripavine ...............................................................................................................................................................................
Thebaine ................................................................................................................................................................................
Dihydroetorphine ...................................................................................................................................................................
Levo-alphacetylmethadol .......................................................................................................................................................
Oxymorphone ........................................................................................................................................................................
Noroxymorphone ...................................................................................................................................................................
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
Schedule
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
2270
2315
2550
7365
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
7379
7460
7471
8333
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9260
9273
9300
9330
9333
9334
9648
9652
9668
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
17627
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
Controlled substance
Drug code
Phenazocine ..........................................................................................................................................................................
Thiafentanil ............................................................................................................................................................................
Piminodine .............................................................................................................................................................................
Racemethorphan ...................................................................................................................................................................
Racemorphan ........................................................................................................................................................................
Alfentanil ................................................................................................................................................................................
Remifentanil ...........................................................................................................................................................................
Sufentanil ...............................................................................................................................................................................
Carfentanil .............................................................................................................................................................................
Tapentadol .............................................................................................................................................................................
Bezitramide ............................................................................................................................................................................
Fentanyl .................................................................................................................................................................................
Moramide-intermediate ..........................................................................................................................................................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytics purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized in 21
U.S.C. 952(a)(2). Authorization will not
extend to the import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–05916 Filed 3–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1169]
Importer of Controlled Substances
Application: Purisys, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Purisys, LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 24, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:23 Mar 22, 2023
Jkt 259001
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 15, 2023,
Purisys, LLC, 1550 Olympic Drive,
Athens, Georgia 30601–1602, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Nabilone ..........................
Phenylacetone .................
Ecgonine ..........................
Levorphanol .....................
Thebaine ..........................
Opium, raw ......................
Opium, powdered ............
Opium, granulated ...........
PO 00000
Frm 00112
Fmt 4703
Noroxymorphone .............
Poppy Straw Concentrate
Tapentadol ......................
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug
code
Schedule
9668
9670
9780
II
II
II
The company plans to import Opium,
Raw (9600), Opium, Powered (9639) and
Opium, Granulated (9640) to
manufacture an Active Pharmaceutical
Ingredient (API) only for distribution to
its customers. The company plans to
import Phenylacetone (8501) and Poppy
Straw Concentrate (9670), to bulk
manufacture other Controlled
substances for distribution to its
customers. The company plans to
import impurities of buprenorphine that
have been determined by DEA to be
captured under Thebaine (9333). In
reference to Marihuana Extract (7350),
Marihuana (7360) and
Tetrahydrocannabinols (7370) the
company plans to import as synthetic.
No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–05939 Filed 3–22–23; 8:45 am]
BILLING CODE P
Drug
code
Schedule
7350
7360
7370
7379
8501
9180
9220
9333
9600
9639
9640
I
I
I
II
II
II
II
II
II
II
II
Sfmt 4703
Controlled substance
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1145]
Importer of Controlled Substances
Application: Myonex Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
E:\FR\FM\23MRN1.SGM
23MRN1
Agencies
[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17623-17627]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05916]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1159]
Importer of Controlled Substances Application: Lipomed
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Lipomed has applied to be registered as an importer of basic
class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 24, 2023. Such persons may also file a written request for a
hearing on the application on or before April 24, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 9, 2023 Lipomed, 150 Cambridepark Drive,
Suite 705, Cambridge, Massachusetts 02140-2300, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)......... 1233 I
Cathinone.................................. 1235 I
Methcathinone.............................. 1237 I
4-Fluoro-N-methylcathinone (4-FMC)......... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone).... 1248 I
4-Methyl-N-ethylcathinone (4-MEC).......... 1249 I
Naphyrone.................................. 1258 I
N-Ethylamphetamine......................... 1475 I
N,N-Dimethylamphetamine.................... 1480 I
Fenethylline............................... 1503 I
Aminorex................................... 1585 I
4-Methylaminorex (cis isomer).............. 1590 I
Gamma Hydroxybutyric Acid.................. 2010 I
Methaqualone............................... 2565 I
Mecloqualone............................... 2572 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-methoxyphenylacetyl)
indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- 7012 I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).... 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)- 7020 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1- 7021 I
(4-fluorobenzyl)-1Hindazole-3-carboxamido)-
3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-)3-carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3methyl-1-oxobutan- 7025 I
2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- 7031 I
2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3- 7036 I
carboxamido) 3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H- 7047 I
indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl- 7048 I
1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1- 7049 I
(5-fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
1-(5-Fluoropentyl)-1H-indazole-3- 7083 I
carboxamide.
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I
phenylpropan-2-yl)-1H-pyrrolo[2,3-
b]pyridine-3-carboxamide).
4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL- 7089 I
BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-
BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-
phenylpropan-2-yl)-1H-indazole-3-
carboximide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
[[Page 17624]]
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- 7225 I
1H-indole-3-carboxylate).
4-methyl-alpha-ethylaminopentiophenone (4- 7245 I
MEAP).
N-ethylhexedrone........................... 7246 I
Alpha-ethyltryptamine...................... 7249 I
Ibogaine................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide................. 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Marihuana extract.......................... 7350 I
Marihuana.................................. 7360 I
Tetrahydrocannabinols...................... 7370 I
Parahexyl.................................. 7374 I
Mescaline.................................. 7381 I
2C-T-2, (2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine).
3,4,5-Trimethoxyamphetamine................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine........... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine........ 7392 I
4-Methyl-2,5-dimethoxyamphetamine.......... 7395 I
2,5-Dimethoxyamphetamine................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
2,5-Dimethoxy-4-ethylamphetamine........... 7399 I
3,4-Methylenedioxyamphetamine.............. 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine.... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine.... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine...... 7404 I
3,4-Methylenedioxymethamphetamine.......... 7405 I
4-Methoxyamphetamine....................... 7411 I
5-Methoxy-N-N-dimethyltryptamine........... 7431 I
Alpha-methyltryptamine..................... 7432 I
Bufotenine................................. 7433 I
Diethyltryptamine.......................... 7434 I
Dimethyltryptamine......................... 7435 I
Psilocybin................................. 7437 I
Psilocyn................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine........ 7439 I
4-chloro-alpha-pyrrolidinovalerophenone (4- 7443 I
chloro-a-PVP).
N-Ethyl-1-phenylcyclohexylamine............ 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.......... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine...... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine..... 7473 I
N-Ethyl-3-piperidyl benzilate.............. 7482 I
N-Methyl-3-piperidyl benzilate............. 7484 I
N-Benzylpiperazine......................... 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-H (2-(2,5-Dimethoxyphenyl) ethanamine).. 7517 I
2C-I (2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)...... 7535 I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)- 7536 I
N-(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................... 7541 I
Pentylone.................................. 7542 I
N-Ethylpentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
one).
[alpha]-PHP, alpha-Pyrrolidinohexanophenone 7544 I
[alpha]-PVP (alpha- 7545 I
pyrrolidinopentiophenone).
[alpha]-PBP (alpha-pyrrolidinobutiophenone) 7546 I
PV8, alpha-Pyrrolidinoheptaphenone......... 7548 I
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
[[Page 17625]]
Norfentanyl................................ 8366 I
Acetyldihydrocodeine....................... 9051 I
Benzylmorphine............................. 9052 I
Codeine-N-oxide............................ 9053 I
Cyprenorphine.............................. 9054 I
Desomorphine............................... 9055 I
Etorphine (except HCl)..................... 9056 I
Codeine methylbromide...................... 9070 I
Dihydromorphine............................ 9145 I
Difenoxin.................................. 9168 I
Heroin..................................... 9200 I
Hydromorphinol............................. 9301 I
Methyldesorphine........................... 9302 I
Methyldihydromorphine...................... 9304 I
Morphine methylbromide..................... 9305 I
Morphine methylsulfonate................... 9306 I
Morphine-N-oxide........................... 9307 I
Myrophine.................................. 9308 I
Nicocodeine................................ 9309 I
Nicomorphine............................... 9312 I
Normorphine................................ 9313 I
Pholcodine................................. 9314 I
Thebacon................................... 9315 I
Acetorphine................................ 9319 I
Drotebanol................................. 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol............................. 9601 I
Allylprodine............................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine............................. 9604 I
Alphamethadol.............................. 9605 I
Benzethidine............................... 9606 I
Betacetylmethadol.......................... 9607 I
Betameprodine.............................. 9608 I
Betamethadol............................... 9609 I
Betaprodine................................ 9611 I
Clonitazene................................ 9612 I
Dextromoramide............................. 9613 I
Diampromide................................ 9615 I
Diethylthiambutene......................... 9616 I
Dimenoxadol................................ 9617 I
Dimepheptanol.............................. 9618 I
Dimethylthiambutene........................ 9619 I
Dioxaphetyl butyrate....................... 9621 I
Dipipanone................................. 9622 I
Ethylmethylthiambutene..................... 9623 I
Etonitazene................................ 9624 I
Etoxeridine................................ 9625 I
Furethidine................................ 9626 I
Hydroxypethidine........................... 9627 I
Ketobemidone............................... 9628 I
Levomoramide............................... 9629 I
Levophenacylmorphan........................ 9631 I
Morpheridine............................... 9632 I
Noracymethadol............................. 9633 I
Norlevorphanol............................. 9634 I
Normethadone............................... 9635 I
Norpipanone................................ 9636 I
Phenadoxone................................ 9637 I
Phenampromide.............................. 9638 I
Phenoperidine.............................. 9641 I
Piritramide................................ 9642 I
Proheptazine............................... 9643 I
Properidine................................ 9644 I
Racemoramide............................... 9645 I
Trimeperidine.............................. 9646 I
Phenomorphan............................... 9647 I
Propiram................................... 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine... 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine................................... 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
[[Page 17626]]
Para-Fluorofentanyl........................ 9812 I
3-Methylfentanyl........................... 9813 I
Alpha-Methylfentanyl....................... 9814 I
Acetyl-alpha-methylfentanyl................ 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin- 9816 I
4-yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl........................... 9822 I
Para-fluorobutyryl fentanyl................ 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Para-chloroisobutyryl fentanyl............. 9826 I
Isobutyryl fentanyl........................ 9827 I
Beta-hydroxyfentanyl....................... 9830 I
Beta-hydroxy-3-methylfentanyl.............. 9831 I
Alpha-methylthiofentanyl................... 9832 I
3-Methylthiofentanyl....................... 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl............................... 9835 I
Beta-hydroxythiofentanyl................... 9836 I
Para-methoxybutyryl fentanyl............... 9837 I
Ocfentanil................................. 9838 I
Valeryl fentanyl........................... 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide).
Cyclopropyl Fentanyl....................... 9845 I
Cyclopentyl fentanyl....................... 9847 I
Fentanyl related-compounds as defined in 21 9850 I
CFR 1308.11(h).
Amphetamine................................ 1100 II
Methamphetamine............................ 1105 II
Lisdexamfetamine........................... 1205 II
Phenmetrazine.............................. 1631 II
Methylphenidate............................ 1724 II
Amobarbital................................ 2125 II
Pentobarbital.............................. 2270 II
Secobarbital............................... 2315 II
Glutethimide............................... 2550 II
Dronabinol in an oral solution in a drug 7365 II
product approved for marketing by the U.S.
Food and Drug Administration (FDA).
Nabilone................................... 7379 II
1-Phenylcyclohexylamine.................... 7460 II
Phencyclidine.............................. 7471 II
ANPP (4-Anilino-N-phenethyl-4-piperidine).. 8333 II
Phenylacetone.............................. 8501 II
1-Piperidinocyclohexanecarbonitrile........ 8603 II
Alphaprodine............................... 9010 II
Anileridine................................ 9020 II
Cocaine.................................... 9041 II
Codeine.................................... 9050 II
Etorphine HCl.............................. 9059 II
Dihydrocodeine............................. 9120 II
Oxycodone.................................. 9143 II
Hydromorphone.............................. 9150 II
Diphenoxylate.............................. 9170 II
Ecgonine................................... 9180 II
Ethylmorphine.............................. 9190 II
Hydrocodone................................ 9193 II
Levomethorphan............................. 9210 II
Levorphanol................................ 9220 II
Isomethadone............................... 9226 II
Meperidine................................. 9230 II
Meperidine-intermediate-A.................. 9232 II
Meperidine intermediate-B.................. 9233 II
Meperidine intermediate-C.................. 9234 II
Metazocine................................. 9240 II
Methadone.................................. 9250 II
Methadone intermediate..................... 9254 II
Metopon.................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms) 9273 II
Morphine................................... 9300 II
Oripavine.................................. 9330 II
Thebaine................................... 9333 II
Dihydroetorphine........................... 9334 II
Levo-alphacetylmethadol.................... 9648 II
Oxymorphone................................ 9652 II
Noroxymorphone............................. 9668 II
[[Page 17627]]
Phenazocine................................ 9715 II
Thiafentanil............................... 9729 II
Piminodine................................. 9730 II
Racemethorphan............................. 9732 II
Racemorphan................................ 9733 II
Alfentanil................................. 9737 II
Remifentanil............................... 9739 II
Sufentanil................................. 9740 II
Carfentanil................................ 9743 II
Tapentadol................................. 9780 II
Bezitramide................................ 9800 II
Fentanyl................................... 9801 II
Moramide-intermediate...................... 9802 II
------------------------------------------------------------------------
The company plans to import analytical reference standards for
distribution to its customers for research and analytics purposes.
Placement of these drug codes onto the company's registration does not
translate into automatic approval of subsequent permit applications to
import controlled substances. Approval of permit applications will
occur only when the registrant's business activity is consistent with
what is authorized in 21 U.S.C. 952(a)(2). Authorization will not
extend to the import of Food and Drug Administration-approved or non-
approved finished dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05916 Filed 3-22-23; 8:45 am]
BILLING CODE P